⌘K

Login Start Free

Home/Filings/4/0001213900-25-116301

4//SEC Filing

Marques Tiago 4

Accession 0001213900-25-116301

CIK 0001841330other

View on SEC.gov Company Profile

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 8:56 AM ET

Size

4.5 KB

Accession

0001213900-25-116301

Insider Transaction Report

Form 4

Period: 2025-11-28

Pasithea Therapeutics Corp.KTTA

DirectorChief Executive Officer

Transactions

Purchase
Common Stock
2025-11-28$0.75/sh+33,333$25,000→ 73,334 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Pasithea Therapeutics Corp.

CIK 0001841330

Entity typeother

Related Parties

1

filerCIK 0001875240

Filing Metadata

Form type: 4
Filed: Nov 30, 7:00 PM ET
Accepted: Dec 1, 8:56 AM ET
Size: 4.5 KB

View on SEC.gov